FDCC
ZBH icon

Foster Dykema Cabot & Co’s Zimmer Biomet ZBH Stock Holding History

Foster Dykema Cabot & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$48K Hold
425
– – 0.01% 162
2023
Q2 		$62K Hold
425
– – 0.01% 160
2023
Q1 		$55K Buy
+425
New +$53.4K 0.01% 140

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Foster Dykema Cabot & Co's ZBH Position: Q3 2023 in Review

Foster Dykema Cabot & Co held its Zimmer Biomet (ZBH) position steady in Q3 2023 at 425 shares worth $48K. The position accounts for 0.01% of the portfolio, ranked #162.

Foster Dykema Cabot & Co first reported a position in ZBH in Q1 2023 and has held it in 3 quarters since. The position peaked at $62K in Q2 2023. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • Foster Dykema Cabot & Co held 425 shares of Zimmer Biomet worth $48K as of Q3 2023.
  • Foster Dykema Cabot & Co left its Zimmer Biomet share count unchanged in Q3 2023.
  • Zimmer Biomet made up 0.01% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #162 holding.
  • Foster Dykema Cabot & Co first reported a position in Zimmer Biomet in Q1 2023 and has held it in 3 quarters since.
  • Foster Dykema Cabot & Co's Zimmer Biomet position peaked at $62K in Q2 2023.
  • 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.